Profitelligence Profitelligence · Filing Ledger Open SYK research →

Form 8-K · Current Report · Filed 2025-01-28

Stryker Announces Retirement of CFO Glenn Boehnlein and Promotion of Preston Wells

On January 28, 2025, Stryker Corporation announced the retirement of its Vice President and Chief Financial Officer, Glenn S.

Filer
Stryker Corporation SYK · NYSE
Filed
Accession
0001193125-25-014415
CIK
0000310764
Signal
High impactHealthcare

Details

Boehnlein, effective April 1, 2025. Preston W. Wells, currently serving as Vice President and Group Chief Financial Officer for Orthopaedics, will be promoted to Vice President and Chief Financial Officer in his place. Boehnlein will continue as an advisor to the CEO until March 31, 2026, and Wells will assume his new role on April 1, 2025.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

CFO Resignation New CFO Appointed
Item 7.01

Regulation FD Disclosure

Regulation FD Disclosure
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$399.90

Next session

-2.2%

Since filing

-18.6%

Latest close

$325.70

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from SYK reporting the same item, with the next session's move:

Exhibits (3)

About Stryker Corporation

Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another SYK filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts